PDT Partners’s Abeona Therapeutics ABEO Stock Holding History

PDT Partners’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,052	Closed	-$365K	–	448
2019 Q2	$365K	Buy	+3,052	New	+$512K	0.02%	328

Other funds holding ABEO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PDT Partners's ABEO Position: Q3 2019 in Review

PDT Partners sold out of Abeona Therapeutics (ABEO) in Q3 2019, closing a stake of 3,052 shares — an estimated $365K sold.

PDT Partners first reported a position in ABEO in Q2 2019 and held it in 1 quarter. The position peaked at $365K in Q2 2019. 79 funds tracked by Wall St. Rank hold ABEO as of Q3 2019.

PDT Partners reported no remaining Abeona Therapeutics position as of Q3 2019 after selling out during the quarter.
PDT Partners sold 3,052 Abeona Therapeutics shares in Q3 2019, an estimated $365K.
PDT Partners first reported a position in Abeona Therapeutics in Q2 2019 and held it in 1 quarter.
PDT Partners's Abeona Therapeutics position peaked at $365K in Q2 2019.
79 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2019.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.